Nosocomial respiratory syncytial virus infection in neonatal units in the United Kingdom

被引:14
|
作者
Thwaites, R [1 ]
Piercy, J
机构
[1] St Marys Hosp, Neonatol Unit, Portsmouth PO3 6AD, Hants, England
[2] Thames Valley Univ, London, England
关键词
nosocomial infection; respiratory syncytial virus;
D O I
10.1080/08035320310021011
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Nosocomial Respiratory Syncytial Virus infections are frequently reported and tend to be more severe, because of comorbidity, such reports, however, are frequently from a single centre. The incidence and outcomes of nosocomial Respiratory Syncytial Virus infection in UK neonatal units over a five year period were estimated by interrogating the Capse Health Care Knowledge Systems database, which contains anonymised details of 55% of UK hospital admissions. A total of 79,642 admissions commenced on the infants' date of birth and contained an ICD-10 code for low birth weight or immaturity. Thirty-seven of the 79,642 admissions also contained a Respiratory Syncytial Virus code. Two (5.4%) with Respiratory Syncytial Virus and 2,736 (3.4%) without Respiratory Syncytial Virus died. Survivors with Respiratory Syncytial Virus codes experienced significantly increased length of stay. In the extreme immaturity sub-group the length of stay was 117.5 days with Respiratory Syncytial Virus and 51.3 days without Respiratory Syncytial Virus ( p = 0.0002). In the low birth weight or other preterm sub-group the length of stay with Respiratory Syncytial Virus was 69.2 and without Respiratory Syncytial Virus 14.7 days ( p < 0.0001). The observed low rate for nosocomial Respiratory Syncytial Virus (0.46/1000 admissions) should be regarded as a minimum. The increased length of stay in infants with Respiratory Syncytial Virus infection emphasises that units should have guidelines to prevent and deal with Respiratory Syncytial Virus outbreaks.
引用
收藏
页码:23 / 25
页数:3
相关论文
共 50 条
  • [31] Receptors for Respiratory Syncytial Virus Infection and Host Factors Regulating the Life Cycle of Respiratory Syncytial Virus
    Feng, Ziheng
    Xu, Lili
    Xie, Zhengde
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
  • [32] Respiratory syncytial virus infection in the modern era
    Ludlow, Martin
    CURRENT OPINION IN INFECTIOUS DISEASES, 2023, 36 (03) : 155 - 163
  • [33] Respiratory Syncytial Virus Infection in Elderly Adults
    Ann R. Falsey
    Edward E. Walsh
    Drugs & Aging, 2005, 22 : 577 - 587
  • [34] The immune response to respiratory syncytial virus infection
    Szczawinska-Poplonyk, Aleksandra
    ALERGIA ASTMA IMMUNOLOGIA, 2008, 13 (04): : 208 - 216
  • [35] Respiratory Syncytial Virus Infection in an Adult with Immunodeficiency
    Sun, Si Y.
    Yao, Xue X.
    Zhang, Ling
    Fu, Ai S.
    Ge, Yan L.
    CLINICAL LABORATORY, 2024, 70 (08) : 1569 - 1573
  • [36] Animal models of respiratory syncytial virus infection
    Taylor, Geraldine
    VACCINE, 2017, 35 (03) : 469 - 480
  • [37] Prevention of respiratory syncytial virus infection.
    Gillet, Y
    ARCHIVES DE PEDIATRIE, 1998, 5 (03): : 333 - 337
  • [38] Vitamin A therapy for children with respiratory syncytial virus infection: A multicenter trial in the United States
    Bresee, JS
    Fischer, M
    Dowell, SF
    Johnston, BD
    Biggs, VM
    Levine, RS
    Lingappa, JR
    Keyserling, HL
    Petersen, KM
    Bak, JR
    Gary, HE
    Sowell, AL
    Rubens, CE
    Anderson, LJ
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1996, 15 (09) : 777 - 782
  • [39] Respiratory syncytial virus infection in elderly adults
    Haber, N.
    MEDECINE ET MALADIES INFECTIEUSES, 2018, 48 (06): : 377 - 382
  • [40] Host response to respiratory syncytial virus infection
    Arruvito, Lourdes
    Raiden, Silvina
    Geffner, Jorge
    CURRENT OPINION IN INFECTIOUS DISEASES, 2015, 28 (03) : 259 - 266